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Abstract—After cardiac surgery operation, severe complications may occur 
in patients due to hypertension. To decrease the chances of complication it is 
necessary to reduce elevated mean arterial pressure (MAP) as soon as possible. 
Continuous infusion of vasodilator drugs, such as sodium nitroprusside 
(Nipride), it is used to reduce MAP quickly in most patients. For maintaining 
the desired blood pressure, a constant monitoring of arterial blood pressure is 
required and a frequently adjust on drug infusion rate. The manual control of ar-
terial blood pressure by clinical professionals it is very demanding and time 
consuming, usually leading to a poor control quality of the hypertension. The 
objective of the study is to develop an automated control procedure of mean ar-
terial pressure (MAP), during acute hypotension, for any patient, without chang-
ing the controller. So, a multi-model adaptive predictive methodology was de-
veloped and, for each model, a Predictive Controller can be a priori designed 
(MMSPGPC). In this paper, a sensitivity analysis was performed and the simu-
lation results showed the importance of weighting factor (φ), which controls the 
initial drug infusion rate, to prevent hypotension and thus preserve patient's 
health. Simulation results, for 51 different patients, showed that the MMSPGPC 
provides a fast control with mean settling time of 04:46 min, undershoots less 
than 10 mmHg and steady-state error less than ± 5 % from the MAP setpoint. 
Keywords—Blood Pressure Control, Multi-Model, Predictive Control, Sodium 
Nitroprusside  
1 Introduction 
Postsurgical complications of hypertension can occur, or to be aggravated, in car-
diac patients. To decrease the probability of complications it is necessary to reduce, at 
the earliest possible stage, the high blood pressure. A way to reach this objective is to 
use a continuous infusion of vasodilator drugs, such as sodium nitroprusside (SNP) 
that can quickly lower the blood pressure in most patients, bearing in mind that an 
overdose of nitride could cause toxic side effects.  
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Drug Delivery Systems are the devices that are used to infuse the drug into the hu-
man body at a particular rate for a given time period. These systems are widely used 
in cardiovascular surgical treatments and Intensive Care Units (ICU). The drugs that 
are used during treatments are mainly used to control the blood pressure. Control of 
such drugs during surgeries and in ICU are very tedious since manual control are done 
by anesthetists which is not accurate and takes time [1]. Manual control may be time 
consuming, and of poor quality. Due to disturbances that perturb pressure, the chang-
ing conditions of patient, and the wide range of response characteristics determining 
the right drug infusion may be difficult. This process causes lots of fatigue to the 
caregivers and increases chances for errors or missing critical events. These situations 
are commonplace in ICU setups. In recent times this situation is being avoided by the 
use of automated drug infusion systems based on therapeutic models. These can im-
prove the drug delivery and can ease the burden of continual monitoring of infusion, 
volume adjustments, data logging, and documentation [2]. Many investigators have 
reported on the use of automated systems for blood pressure control [3, 4, 5, 6] and 
multiple drug infusion systems to regulate hemodynamics such as cardiac output and 
mean arterial blood pressure (MAP) [7], [8]. 
The objective of this paper is to develop an adaptive method control for a blood 
pressure management for any patient without changing the controller. Blood pressure 
control of a patient under the influence of the vasodilator SNP is modelled through an 
uncertain model [9], [10]. A multi-model approach is used in order to control the 
blood pressure under the influence of this drug. Multi-model approaches are common-
ly applied to control non-linear systems that operates in long ranges [11], [12]. The 
basic idea of multi-model approach consists in decompose the system's operating 
range into a number of operating regimes that completely cover the chosen trajectory 
[12]. There are, basically, two approaches for multi-model. The first one consists of 
designing a set of suitable controllers (one for each operating regime) and to calculate 
weighting factors to them as showed by the study by [12]. Moreover, an sensitivity 
analysis of the parameter (φ) which regulates the initial drug infusion rate was per-
formed. 
2 Problem Formulation 
The pressure exerted by circulating blood upon the blood vessels is termed as 
Blood Pressure (BP). It usually refers to the arterial pressure of the systemic circula-
tion. During each heartbeat, blood pressure varies between a maximum and a mini-
mum pressure [13]. The pressure exerted due to pumping of heart causes systolic 
blood pressure (SBP) and the pressure exerted by blood vessels causes' diastolic blood 
pressure (DBP). The blood pressure in circulation is principally due to heart rate. A 
person's blood pressure is usually expressed in terms of the systolic pressure over 
diastolic pressure and is measured in millimeters of mercury (mmHg), for example 
120/80. Blood pressure that is pathologically low is called hypotension and which is 
pathologically high is hypertension. In most cases, we measure the mean arterial pres-
sure (MAP) by using equation (1) [13].  
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 𝑀𝐴𝑃 =	 [𝑆𝐵𝑃 + (𝐷𝐵𝑃 × 2)] 3⁄  (1) 
After cardiac operation, severe complications may occur in patients due to hyper-
tension. It may damage heart cells, causes excessive bleeding, bursting of veins in 
brains etc. To decrease the chances of complication, the MAP must be maintained at a 
desired level. This is achieved by intravenous infusion of suitable vasodilator drugs 
such as sodium nitroprusside (SNP), Nitroglycerin, etc., which are commonly used for 
the treatment of hypertensive cardiac patients. The infusion of these drugs will gener-
ate Nitric Oxide (NO) and there by reduces the MAP. It causes widening of blood 
vessels and has less side effects [14]. 
The American College of Cardiology (ACC)/American Heart Association (AHA) 
hypertension guideline published in November 2017 introduced new blood-pressure 
categories lowering the threshold for the diagnosis of hypertension. Where, Hyperten-
sion is defined by a systolic blood pressure greater than 130 mmHg or a diastolic 
pressure greater than 80 mmHg. Table 1 shows the blood pressure classification estab-
lished by [15]. The categories of blood pressure from normal to stage 2 hypertension. 
Table 1.  Blood pressure classification (from [15]) 
BP Category SBP (mmHg)  DBP (mmHg) 
Normal < 120 and < 80 
Elevated BP 120 – 129 and < 80 
Stage 1 hypertension 130 – 139 or 80 - 89 
Stage 2 hypertension ≥ 140 or ≥ 90 
2.1 Blood pressure control systems 
The objective of the control system is to regulate the MAP at any setpoint and 
maintain the setpoint determined in the presence of undesired disturbances and chang-
ing conditions of patient. Since it is desirable to develop a system that will be used in 
clinical applications, it is essential to establish realistic design specifications. In gen-
eral, the control system must be able to control MAP as quickly as possible, while 
meeting control specifications, increasing system security and preserving patient 
health. 
The closed loop control system should respond quickly and smoothly to changes in 
the MAP setpoint (performed by the health care professional) without a excessive 
overshoot. The closed loop system shall minimize the effects of undesired disturb-
ances, such as measurement errors, resulting from calibration errors and stochastic 
background noise. Since it is desired to use the same control system for many differ-
ent patients and it is not possible to have a separate model for each patient (for practi-
cal reasons), it should have a closed-loop system that is insensitive to changing condi-
tions of patient (it must meet the specifications for any patient). 
Based on clinical experiences [9], it is possible to determine the control specifica-
tions as follows: 
• Settling time less than 15 minutes; 
• Overshoot less than 15 %; 
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• Steady-state error less than ± 5 % from the MAP setpoint; 
• Minimum sensitivity to changing conditions of patient. 
Figure 1 show the main elements of the system with controller, infusion pump, 
sensor and patient. The system input R(s) is the MAP setpoint, and the output Y(s) is 
the actual change in pressure. The difference between the desired change and the 
measured change in blood pressure forms a signal used by the controller to determine 
set values for the infusion pump, which is responsible for infusing the drug into the 
patient. 
 
Fig. 1. Blood Pressure Control System 
2.2 Infusion pump model 
The infusion pump model depends directly on the mechanical design. A simple in-
fusion pump is allowed in which the infusion rate variation at the output is equal to 
the input voltage adjustment at the pump: 
 ?̇?(𝑡) = 𝑣(𝑡) (2) 







This is equivalent to saying that from an input/output perspective, the infusion 
pump has the impulse response h(t) = 1, for t ≥ 0. 
2.3 Patient modeling 
A model for the mean arterial pressure (MAP) of a patient under the influence of 
sodium nitroprusside (Nipride) can be represented, as in [9], by: 
 𝑀𝐴𝑃(𝑡) 	= 	𝑃=(𝑡) − ∆𝑃(𝑡) + 𝑣(𝑡) (4) 
Where P0 is the initial blood pressure, also called a background pressure, P(t) is the 
pressure differential due to infusion of Nipride, and v(t) is a stochastic background 
noise. In this paper it is assumed that P0 is constant. A continuous-time deterministic 
model describing the relationship between the change in the blood pressure, ΔP(s), 
and drug infusion rate, I(s), [9] is as follows: 
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Where K is drug sensitivity, α is the recirculation constant, Ti is the initial transport 
delay, Tc is the recirculation time delay, and τ is a time constant. The corresponding 
discrete-time deterministic model for this process can be given as follows: 
∆𝑃(𝑡) = 	 K
BL(7MF7NKBN)
<OPQKBQ
𝐼(𝑡);	𝑏= > 0 (6) 
Where q-1 denotes a unit delay operator, parameters bo, bm, a1, d, and m are ob-
tained from the sampled version of the continuous-time model given in (5). A range of 
typical values for the parameters of the model (5) for different patients is given by [9] 
and are found in Table 2. 
Table 2.  Range of values for parameters of the continuous patient model [9] 
Parameter Minimum Maximum Nominal 
K 0.25 9 1 
α 0 0.4 0.1 
τ (s) 30 60 40 
Ti (s) 20 60 40 
Tc (s) 30 75 45 
 
For a given patient, time delays are unknown, but are assumed to be constant over 
a long period of time whereas the parameters K, α and τ change during the infusion 
procedure. In this work, it is assumed that the parameters change in an exponential 
manner and modeled as follows [5]: 
 𝑝𝑎𝑟(𝑘) = 𝑝𝑎𝑟(0)(2 − 𝑒O[/]) (7) 
For increase and decrease in the parameter value, respectively, where par(t) repre-
sents the parameter of the continuous-time model and γ is the change time constant. 
Thus, the controller when tuned for a particular patient, should be able to handle time-
varying parameters and initially unknown time delays. 
3 Smith Predictor Based Generalized Predictive Control 
The Smith Predictor (SP), the first control system proposed in the literature that in-
troduces a delay compensator [16], improves the performance of a system with a 
delay compared to other techniques, such as PID, especially when the delay is domi-
nant (greater than twice the dominant time constant of the system). 
Using a SP instead of an optimal predictor in generalized predictive controllers 
(GPC) for stable plants and in real applications have advantages [17], [18], [19], 
namely in the case of time-delay systems. Setting the GPC algorithm, it is possible to 
improve the robustness of the closed-loop system while maintaining the nominal per-
formance. A Smith Predictor Based Generalized Predictive Control (SPGPC) uses a 
Smith predictor structure to compute the predictions of the output of the plant and to 
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calculate a sequence of future control signals in order to minimize a multistage cost 
function defined over a control horizon, as described in [17]. 
4 Multiple Model SPGPC Method 
The high variability between patients as well as the variability within the same pa-
tient on different days and even within the same patient during a given experimental 
run, is the greatest control challenge for this system. This became evident in the first 
few canine experiments using a fixed prediction model derived from a nonlinear mod-
el [20] and step responses tests performed on the canine. So, a different approach 
based on using multiple models was considered. In Rao et al. [20] a considerable 
amount of research in a Multiple Model Adaptive Control (MMAC) framework using 
a bank of several model controller pairs was performed. 
The Multiple Model SPGPC (MMSPGPC) procedure, shown in Figure 2, is a con-
trol strategy that can identify and then adapt to changing characteristics. The 
MMSPGPC uses a finite range of models (assumed to be reasonable representations 
of possible patients) from which to identify the patient. Single-model adaptive control 
schemes using some sort of recursive parameter estimation have, in essence, an infi-
nite range of models from which to identify the patient. MMSPGPC has an advantage 
over single-model schemes, because it limits the identification to one of a finite set of 
possible models, all of which are realistic [4]. The MMSPGPC is based upon the 
assumption that the patient can be represented by a finite number of models and, for 
each model a predictive controller can be priori designed. An adaptive mechanism is 
then needed to decide which controller should be dominant for a given patient. One 
procedure for solving this problem is to consider a weighted sum of all the controller 
outputs, where the weighting factors are determined by the relative residuals between 
the patient response and the model responses [21]. 
In Figure 2, the system error, e, is expressed as: 
 𝑒(𝑘) = 𝑝(𝑘) − 𝑝^ (8) 
Where k is the sampling time and pc, is the commanded or setpoint pressure level. 
4.1 Controller bank design 
The controller bank contains a set of Smith Predictor Based Generalized Predictive 
Controllers where for each model, present in the model bank, a corresponding SPGPC 
has been tuned. The SPGPC uses a smith predictor structure to compute the predic-
tions of the system output and to calculate a sequence of future control signals in 
order to minimize a multistage cost function defined over a control horizon, as fol-
lows [21]: 
𝐽(𝑁<, 𝑁b) = ∑ 𝛿(𝑗)[𝑦g(𝑡 + 𝑗|𝑡) − 𝑤(𝑡 + 𝑗)]b
jk
lmjQ + ∑ 𝜆(𝑖)[∆𝑢(𝑡 + 𝑖 − 1)]
bjkOq
rm<  (9) 
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Fig. 2. Multiple Model SPGPC Schema (Adapted from [21]) 
Where 𝑁< and 𝑁b are the minimum and maximum costing horizons, respectively, d 
is the delay of the process model, δ(j) and λ(j) are weighting sequences, w(t+j) is a 
future set-point or reference sequence, Δu(t) is the incremental control action Δu(t) = 
u(t) - u(t - 1) and (t + j|t) is the j-step ahead prediction of the system output on data up 
to time t. The performance of the predictive controller depends on the proper tuning of 
the prediction horizon N2, and the weighting factor λ. Using a non-automatic tuning 
method, an initial choice of the parameters was performed and then modified until the 
project specifications were met. This final adjustment is done by trial and error, based 
on the fact that the increase in λ decreases the magnitude (effort) of the control signal, 
making the response slower and smoother. However, the increase in λ provides great-
er robustness. The simultaneous increase in the prediction and control horizons con-
tributes to improve controller stability, undershoot and settling time. According to 
[22] the value of the prediction horizon must be equal: 




Where T is the sampling time, dmax is the number of samples contained in the max-
imum estimated dead time and Ts is the settling time. Thus, after calculating the pre-
diction horizon, the λ were tuned by trial and error.  
4.2 Model bank design 
The model bank consists of a number of models with constant parameters charac-
terizing the individual patient subspace [23]. Since these models should have the same 
structure as the patient, the following discrete model will describe them: 
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𝑢(𝑘); 	𝑏=l > 0	(𝑗 = 1,… ,𝑁) (11) 
Where N is the number of models and the output pressure from model j is: 
  (12) 
Where ∆Pmj(k)is the change in the jth model output, u(k) is the model input, P0 is 
the initial value of each model’s output and equals the initial system output. 
The relative residual Rj2(k) will be defined as the normalized squared error between 
patient and model, i.e., as follows: 
  (13) 
At each sample time k, the model that has the smallest residual is defined as the 
matching model, which is used to represent the patient t characteristics. 
To determine the number of models needed and the range of drug sensitivity that 
each model could cover, a SPGPC was set up. Then to find the maximum drug sensi-
tivity that the model could control, drug sensitivity of the patient was increased until a 
10 percent overshoot occurred or a settling time more than 400 seconds. This was the 
maximum drug sensitivity allowed for the model. Figure 3 shows the flowchart de-
scribing the algorithm to determine the range of drug sensitivity that each model could 
cover. 
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Kmin. the minimum drug sensitivity; 
 αnominal, τnominal and Tc,nominal the nominal values of the parameters;  
Ti,max. the maximum time delay; 
 Ts the settling time; 
Δ the increase parameter (initially high and decreases until reaching the wanted accuracy value)
Fig. 3. Algorithm to determine the range of drug sensi 
4.3 Control algorithm 
To reach desirable system performance and to guarantee patient safety, the control 
algorithm should converge quickly to the optimal values and should react to time 
varying patient characteristics, as well as ensure a reasonable rate of blood pressure 
change. Thus, the control, uc(k), was computed as a weighted sum of controller bank 
signals, and represented by the following equation: 
 𝑢^(𝑘) = ∑ 𝑊l(𝑘)𝑢l(𝑘)jlm<  (14) 
Where N is the number of models, uj(k) are the individual controller outputs and 
Wj(k) are the weighting factors. The weights were selected as follows: 
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• Bounding away from zero 














Where Rj(k) are the residuals and defined in (13), V is a parameter controlling the 
convergence rate of W'j(k) with Rj(k) and δ is a threshold to limit the importance of 
past information. Equations (14) and (15) express the basic relationship between the 
control, the weighting factors, and the relative residuals. Equation (16) is used to 
delimit the importance of past information enabling the adaptive mechanism quickly 
react to the new information about the patient characteristics. Equation (17) is used to 
normalize the weighting factors so that their square sum is equal to unity. 
From (15), it is observed that a large value of δ will improve the sensitivity of the 
algorithm to the new patient information. The parameter V in (15) plays an important 
role in controlling the convergence rate of Wj(k). Since the drug sensitivity may be 
located in any position in the patient parameter space, the values for Wj(0) were as-
sumed to be uniform and calculated by: 
 𝑊l(0) = 𝑊l´(0) =
<
j
	(𝑗 = 1,… ,𝑁) (18) 
4.4 Safety functions 
For patient safety, two nonlinear units, F1 and F2, are built into the system. The 
nonlinear unit limiting infusion rate is given by 
 𝑢 = 𝐹<(𝑢) = 
0, 𝑖𝑓	𝑢 < 0;
𝑢, 𝑖𝑓	𝑢 ≤ 𝑈;
𝑈, 𝑖𝑓	𝑢 > 𝑈
 (19) 
Where UM is the allowed maximum infusion rate. For patient safety, the infusion 
rate should be reduced under hypotension, i.e., when there is a drop-in excess of 20 
mmHg from the set point. Thus, other nonlinear unit is used to turn off the infusion if 
and when hypotension occurs. Its expression is given by: 
 𝐹b(𝑝(𝑘)) = 
1, 𝑓𝑜𝑟	𝑝(𝑘) ≥ 𝑝
0, 𝑓𝑜𝑟	𝑝(𝑘) < 𝑝
 (20) 
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where pL is defined as: 
 𝑝 = 	𝑝^ − 20 (21) 
4.5 Regulating the initial infusion rate 
Since the control variable uc(k) calculated by (14) will be in error before the con-
vergence of Wj (k), and this error can cause a large undershot for patients with high 
drug sensitivity, the algorithm consisting of (14) to (17) was modified as follows: 
𝑢(𝑘) 	= 
𝜑	𝑢^(𝑘), 𝑓𝑜𝑟	𝑘	 ≤ 𝑑u	
[𝜑 +	𝜑<(𝑘 −	𝑑u)]	𝑢^(𝑘), 	𝑓𝑜𝑟	𝑑u < 𝑘 < (𝑑u + 𝐷)	
𝑢^(𝑘), 𝑓𝑜𝑟	𝑘 ≥ (𝑑u + 𝐷)	
 (22) 




𝑑u = 𝑇r(𝑚á𝑥. )/𝑇 with T the sampling time. 𝜑 is used to regulate the initial infusion 
rate so as to prevent large undershoot. The value of 𝜑 should place the initial control 
variable near the steady-state control input required by the patient with the highest 
expected drug sensitivity. 𝜑< is then set so that the increment of the initial infusion 
rate ensures smooth reduction of pressure. Note that because of this conservative 
initial control policy, a large error could persist and subsequently cause an undershoot 
of the system output. To eliminate this behavior, the jth model error 𝑒ul(𝑘) was de-
creased during the initial control period as follows: 
𝑒ul(𝑘) = 𝛽ul(𝑘) × {𝑃ul(𝑘) − 𝑝^}; 𝑓𝑜𝑟	(j = 1, …, N) (23) 
where 𝛽ul are modifying coefficients defined as 
£
𝛽ul(𝑘) ≤ 1	𝑝𝑎𝑟𝑎	𝑘 ≤ 𝑑u + 𝐷
𝛽ul(𝑘) = 1	𝑝𝑎𝑟𝑎	𝑘 > 𝑑u + 𝐷
 (24) 
5 Results and Discussion 
5.1 Computer simulation 
Computer simulations were used to evaluate the response of the system design 
(figure 2 a representative patient parameter envelope. It was studied the response to 
step command in the presence of system background noise, the adaptation of the algo-
rithm to time-varying patient parameter. 
Table 3 shows the model bank and controller bank, which were obtained from the 
algorithm in figure 3 where the 8 models used in the model bank and their respective 
controllers were obtained. 
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Table 3.  Parameters of Controllers and Models 
Nº Controller Model 




60 45 40 0.4 
2 6 0.37 
3 8 0.53 
4 18 0.87 
5 30 1.52 
6 80 2.26 
7 150 3.51 
8 250 5.66 
 
The coefficient V in (15) was determined by computer simulation as described in 
[12]. Thus, V was chosen to be 0.05. The initial weighting factors were assumed to be 




The parameter that regulate the initial infusion rate (φ in (22)), was determined by 
computer simulation (as described in subsection 5.2 Parametric sensitivity analysis). 
The results obtained by sensitivity analysis showed that the undershoot specification 
can be satisfied when φ = φ1 = 0.2. 
The modification of βmj is needed only for the control of lower drug sensitivity, so 
that some components of βmj, such as βm5, ..., βm8, corresponding to the controller 
outputs for high drug sensitivity, can directly be set to unity. The other components, 
βm1, ..., βm4, were determined by trial and error. Their values are listed in Table 4. 
Table 4.  Parameters of control algorithm 
V 𝜹 𝑾𝒋(𝟎) 𝝋 𝝋𝟏 𝒅𝒎 D  
0.05 0.01 1/8 0.2 0.2 6 4  
𝜷𝒎𝟏 𝜷𝒎𝟐 𝜷𝒎𝟑 𝜷𝒎𝟒 𝜷𝒎𝟓 𝜷𝒎𝟔 𝜷𝒎𝟕 𝜷𝒎𝟖 
0.75 0.85 0.85 0.85 1 1 1 1 
 
The regime blood pressure considered was 150 mmHg and the multi-model con-
troller deviation reference of -50 mmHg. The system background noise v(t) was simu-
lated as a white Gaussian noise sequence with standard deviation of 4 mmHg. The 
simulations were performed with the patient parameters: Tc = 50 s, τ, = 45 s, α = 0.4, 
as well as for the different values of drug sensitivity (K) and patient delay time (Ti). 
The blood pressure (mmHg), the deviation in infusion rate (ml/h) and the weighting 
factors convergence of several patients with the parameters: Tc = 50 s, τ, = 45 s, α = 
0.4, as well as for different drug sensitivity (0.25 ≤ K ≤ 9) and patient delay time (Ti = 
20, 40 or 60 s) obtained are shown in figures 4 to 7. In all cases the drug sensitivity 
and delay time were considered exponentially time-varying during the procedure by 
Equation (7). 
Considering the data obtained by simulations (figures 4 to 7) the convergence pro-
cess of the weighting factors Wj(k), the global control effort is calculated to the closest 
model (less residual error), as such as the schema leads the blood pressure of the cho-
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sen patient to the given reference, making drug infusion rate and the blood pressure to 
change in a smooth way. These responses also show the robustness of Multi-Model 
SPGPC algorithm even in the presence of the system background noise and variation 
of patient parameters. Simulation results, for 51 different patients, showed that the 
MMSPGPC provides a fast control with mean settling time of 04:46 min. (06:00 min. 
maximum and 02:30 min. minimum), undershoots less than 10 mmHg and steady-
state error less than ± 5 % from the MAP setpoint. 
 
Fig. 4. Simulation results for drug sensitivity K = 0.25 and delay time Ti = 40 s 
5.2 Parametric sensitivity analysis 
The parameter φ, in equation (22), is used to regulate the initial infusion rate, in 
order to prevent large undershoots. The value of φ should place the initial control 
variable near the steady-state control input required by the patient with the highest 
expected sensitivity. φ1 is then set so that the increment of the initial infusion rate 
ensures smooth reduction of pressure. 
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Fig. 5. Simulation results for drug sensitivity K = 2.4 and delay time Ti = 20 s 
 
Fig. 6. Simulation results for drug sensitivity K = 9.0 and delay time Ti = 40 s 
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Fig. 7. Simulation results for drug sensitivity K = 9.0 and delay time Ti = 60 s 
The sensitivity analysis was performed, varying φ and verifying its influence on 
performance indices (Ts and undershoot). Table 5 shows the relationship between the 
parameter φ and the performance indices obtained for patients with low sensitivity (k 
= 0.25) and high sensitivity (k = 9). The simulation results (see table 5) showed that 
without initial regulation of the drug infusion rate (i.e., φ = 1), large undershoots (40.5 
mmHg) are observed for patients with high sensitivity. This demonstrates the need of 
the algorithm described in equation (22), which to reduce the undershoots for patients 
with high sensitivity, in order to prevent hypotension and thus preserve the patient's 
health. 
Table 5.  Relationship between the values of φ, Ts and undershoot 
 Ts (seconds) Undershoot (mmHg) 
 Drug Sensitivity Drug Sensitivity 








1 345 90 0 40.5 
0.5 330 105 0 21.4 
0.4 315 120 0 18.3 
0.3 300 135 0 15.2 
0.2 300 240 0 4.4 
0.1 315 270 6.2 18.1 
0.05 360 315 14.5 26.2 
 
The results in Table 5 shows that the undershoots are acceptable (≤ 20 mmHg from 
the setpoint) only for 0.4 ≤ φ ≤ 0.1. 
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Figure 9 show larger undershoots for patients with high sensitivity, and an expo-
nential reduction of undershoots for lower values of φ. However, an overly conserva-
tive initial control policy (φ < 0.2), a large error could persist and subsequently cause 
a large undershoot. 
 
Fig. 8. Ts for the different values of φ 
 
Fig. 9. Undershoot for the different values of φ 
6 Conclusion 
The simulated results show that the Multi-Model SPGPC algorithm is robust even 
in the presence of the system background noise and variation of patient parameters. 
In an automatic blood pressure control system, large undershoots can occur, espe-
cially for patient with high drug sensitivity. When the patient has high drug sensitivity 
and is being controlled by a low drug sensitivity model, large overshoots will occur. 
In the MMSGPC method this may occur at the beginning of the control process, be-
fore the convergence of the weight factors. Therefore, it is necessary to regulate the 
initial infusion rate, to prevent hypotension and thus preserve the patient's health. 
The developed algorithm that regulates the initial infusion rate (subsection 4.5) is 
very important for the MMSPGPC performance. The sensitivity analysis of the pa-
rameter φ showed that the algorithm (described in equation (22)) was able to reduce 
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where without initial reduction of the infusion rate (i.e., φ = 1), the undershoot was 
40.5 mmHg and for φ = 0.2, the undershoot was 4.4 mmHg, with a maximum settling 
time of 300 seconds.  
In the future, robustness tests can be implemented with the submission of the sys-
tem to a larger range of disturbances. Thus, the presented approach could be imple-
mented in a microcontroller, as first approach, in tests with animals. 
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